Validation of a 4-item score predicting hip fracture and mortality risk among elderly women

Annals of Family Medicine

Volumn 5, Issue 1, 2007, Pages 48-56

  Albertsson, Daniel M ^a,b,d   Mellström, Dan ^a   Petersson, Christer ^b   Eggertsen, Robert ^a,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Kronoberg County Council   (Sweden)

^c Mölnlycke Primary Health Care and Research Center   (Sweden)

^d FoU Centrum   (Sweden)

Author keywords

Aged; Fractures, bone; Hip fractures; Mortality; Primary health care; Risk assessment; Risk factors; Sweden; Women

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; ELDERLY CARE; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; POPULATION RESEARCH; QUESTIONNAIRE; RISK FACTOR; SWEDEN;

AGED; AGED, 80 AND OVER; FEMALE; GERIATRIC ASSESSMENT; HEALTH STATUS INDICATORS; HIP FRACTURES; HUMANS; LOGISTIC MODELS; MALE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SWEDEN;

EID: 33846688098     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.602     Document Type: Article

References (46)

1. Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7(5):407-413.
2. Kanis JA, Johnell O, Oden A, et al. Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporos Int. 2000;11(2):120-127.
3. Sernbo I, Johnell O. Consequences of a hip fracture: a prospective study over 1 year. Osteoporos Int. 1993;3(3):148-153.
4. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332(12):767-773.
5. Black DM, Steinbuch M, Palermo L, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int. 2001;12(7):519-528.
6. Dargent-Molina P, Favier F, Grandjean H, et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet. 1996;348(9021):145-149.
7. Taylor BC, Schreiner PJ, Stone KL, et al. Long-term prediction of incident hip fracture risk in elderly white women: Study of Osteoporotic Fractures. J Am Geriatr Soc. 2004;52(9):1479-1486.
8. De Laet CE, Van Hout BA, Burger H, et al. Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res. 1998;13(10):1587-1593.
9. De Laet CE, van Hout BA, Burger H, Hofman A, Pols HA. Bone density and risk of hip fracture in men and women: cross sectional analysis. BMJ. 1997;315(7102):221-225.
10. Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35(2):375-382.
11. McGrother CW, Donaldson MM, Clayton D, Abrams KR, Clarke M. Evaluation of a hip fracture risk score for assessing elderly women: the Melton Osteoporotic Fracture (MOF) study. Osteoporos Int. 2002;13(1):89-96.
12. Dargent-Molina P, Poitiers F, Breart G. In elderly women weight is the best predictor of a very low bone mineral density: evidence from the EPIDOS study. Osteoporos Int. 2000;11(10):881-888.
13. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15(4):721-739.
14. Gunnes M, Mellstrom D, Johnell O. How well can a previous fracture indicate a new fracture? A questionnaire study of 29,802 postmenopausal women. Acta Orthop Scand. 1998;69(5):508-512.
15. Albertsson D, Mellström D, Eggertsen R. Risk group for hip fracture in elderly women identified by primary care questionnaire - clinical implications. Ups J Med Sci. 2006;111(2):179-187.
16. Kullenberg R. Reference database for dual X-ray and laser Calscan bone densitometer. J Clin Densitom. 2003;6(4):367-372.
17. Jonsson B, Gardsell P, Johnell O, Redlund-Johnell I, Sernbo I. Differences in fracture pattern between an urban and a rural population: a comparative population-based study in southern Sweden. Osteoporos Int. 1992;2(6):269-273.
18. Jonsson B, Gardsell P, Johnell O, Sernbo I, Gullberg B. Life-style and different fracture prevalence: a cross-sectional comparative population-based study. Calcif Tissue Int. 1993;52(6):425-433.
19. Ensrud KE, Black DM, Palermo L, et al. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med. 1997;157(22):2617-2624.
20. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998;280(24):2077- 2082.
21. Hochberg MC, Thompson DE, Black DM, et al. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res. 2005;20(6):971-976.
22. Johnell O, Jonsson B, Jonsson L, Black D. Cost effectiveness of alendronate (Fosamax) for the treatment of osteoporosis and prevention of fractures. Pharmacoeconomics. 2003;21(5):305-314.
23. Wehren LE, Siris ES. Beyond bone mineral density: can existing clinical risk assessment instruments identify women at increased risk of osteoporosis? J Intern Med. 2004;256(5):375-380.
24. Bauer DC, Browner WS, Cauley JA, et al. Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1993;118(9):657-665.
25. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology. 1991;2(1):16-25.
26. Feskanich D, Willett W, Colditz G. Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA. 2002;288(18):2300- 2306.
27. Ringsberg KA, Gardsell P, Johnell O, Josefsson PO, Obrant KJ. The impact of long-term moderate physical activity on functional performance, bone mineral density and fracture incidence in elderly women. Gerontology. 2001;47(1):15-20.
28. Wilkins CH, Birge SJ. Prevention of osteoporotic fractures in the elderly. Am J Med. 2005;118(11):1190-1195.
29. Fiatarone MA, Marks EC, Ryan ND, et al. High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA. 1990;263(22):3029- 3034.
30. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ. 1997;315(7112):841-846.
31. Kanis JA, Johnell O, Oden A, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005;16(2):155-162.
32. Campbell AJ, Robertson MC, Gardner MM, Norton RN, Buchner DM. Falls prevention over 2 years: a randomized controlled trial in women 80 years and older. Age Ageing. 1999;28(6):513-518.
33. Day L, Fildes B, Gordon I, et al. Randomised factorial trial of falls prevention among older people living in their own homes. BMJ. 2002;325(7356):128-133.
34. Cumming RG, Thomas M, Szonyi G, et al. Home visits by an occupational therapist for assessment and modification of environmental hazards: a randomized trial of falls prevention. J Am Geriatr Soc. 1999;47(12):1397-1402.
35. Campbell AJ, Robertson MC, Gardner MM, Norton RN, Buchner DM. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc. 1999;47(7):850-853.
36. Gillespie LD, Gillespie WJ, Robertson MC, et al. Interventions for preventing falls in elderly people. Cochrane Database Syst Rev. 2003;(4):CD000340.
37. Lauritzen JB, Petersen MM, Lund B. Effect of external hip protectors on hip fractures. Lancet. 1993;341(8836):11-13.
38. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA. 2004;291(16):1999-2006.
39. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337(10):670-676.
40. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992;327(23):1637-1642.
41. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003;326(7387):469-474.
42. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005;293(18):2257-2264.
43. Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res. 2004;19(3):370-378.
44. Kanis JA, Black D, Cooper C, et al. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int. 2002;13(7):527-536.
45. Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab. 2000;85(11):4118-4124.
46. Johnell O, Kanis JA, Oden A, et al. Mortality after osteoporotic fractures. Osteoporos Int. 2004;15(1):38-42.